The following corrections should be made to our article....
read full comment
Comment on: Sheng et al. Diabetology & Metabolic Syndrome, 3:6
Table 1 (Doris Mayer, 19 December 2011)
Please note that insulin signaling results in GSK-3 inactivation. GSK-3 is negatively regulated by phosphorylation.
read full comment
Comment on: Werner et al. Diabetology & Metabolic Syndrome, 3:13
Infant Forumlas and T1DM (Chris Exley, 05 October 2010)
Considering our recent publication in BMC Pediatrics (http://www.biomedcentral.com/1471-2431/10/63) on the aluminium content of infant formulas it would be extremely interesting to look at how the exposure of these infants to aluminium varied between the control and T1DM groups. We have recently shown that aluminium might have a role to play in T2DM (Ward et al.,(2008) JIB 102, 371-375; Exley et al., (2010) JIB 104, 1125-1129)while exposure to aluminium is known to produce an anaemia which is unresponsive to iron. Of course, aluminium is also a powerful pro-oxidant and one would want to be wary of situations in which the diet included high amounts of both iron and aluminium. There is too much aluminium in infant formulas and we can only begin to understand how this might be acting...
read full comment
Comment on: Ashraf et al. Diabetology & Metabolic Syndrome, 2:58
missing letter in author 3 name and an additional space (Hekmat El Magdoub, 15 July 2010)
Dear Post Publication Team,
First, I would like to express my sincere appreciation to the efforts done by Diabetology & Metabolic Syndrome team, so as to have our work presented in its final format, and published on the reputable BMC.
Second, regarding our manuscript, there are two minor comments:
1. paragraph B.9.1, third sentence: [fasting serum insulin (µ U/ml)….], I do not think there
should be a blank space between “µ” and “U”.
2. It concerns the authors names, and I hopefully wish you can have it corrected, it concerns author 3, Dr. Lamiaa N Hammad, actually her first name is “Lamiaa” with double “a” at its end, NOT “lamia”. Actually, it was...
read full comment
RSS
Latest comments
Corrigendum (Chang-sheng Sheng, 19 December 2011)
The following corrections should be made to our article.... read full comment
Comment on: Sheng et al. Diabetology & Metabolic Syndrome, 3:6
Table 1 (Doris Mayer, 19 December 2011)
Please note that insulin signaling results in GSK-3 inactivation. GSK-3 is negatively regulated by phosphorylation. read full comment
Comment on: Werner et al. Diabetology & Metabolic Syndrome, 3:13
Infant Forumlas and T1DM (Chris Exley, 05 October 2010)
Considering our recent publication in BMC Pediatrics (http://www.biomedcentral.com/1471-2431/10/63) on the aluminium content of infant formulas it would be extremely interesting to look at how the exposure of these infants to aluminium varied between the control and T1DM groups. We have recently shown that aluminium might have a role to play in T2DM (Ward et al.,(2008) JIB 102, 371-375; Exley et al., (2010) JIB 104, 1125-1129)while exposure to aluminium is known to produce an anaemia which is unresponsive to iron. Of course, aluminium is also a powerful pro-oxidant and one would want to be wary of situations in which the diet included high amounts of both iron and aluminium.
There is too much aluminium in infant formulas and we can only begin to understand how this might be acting... read full comment
Comment on: Ashraf et al. Diabetology & Metabolic Syndrome, 2:58
missing letter in author 3 name and an additional space (Hekmat El Magdoub, 15 July 2010)
Dear Post Publication Team,
First, I would like to express my sincere appreciation to the efforts done by Diabetology & Metabolic Syndrome team, so as to have our work presented in its final format, and published on the reputable BMC.
Second, regarding our manuscript, there are two minor comments:
1. paragraph B.9.1, third sentence: [fasting serum insulin (µ U/ml)….], I do not think there
should be a blank space between “µ” and “U”.
2. It concerns the authors names, and I hopefully wish you can have it corrected, it concerns author 3, Dr. Lamiaa N Hammad, actually her first name is “Lamiaa” with double “a” at its end, NOT “lamia”. Actually, it was... read full comment
Comment on: El Mesallamy et al. Diabetology & Metabolic Syndrome, 2:46